Women with polycystic ovary syndrome (PCOS) are often assumed, a priori, to be at
increased risk for cardiovascular disease (CVD), given the high prevalence of the metabolic …

PCOS is not only the most frequent cause of oligomenorrhea in young women, but also a
metabolic disorder characterized by insulin resistance, glucose intolerance, dyslipidemia …

Objective: To assess effects of vitamin D and Calcium (Ca) on hormonal and metabolic
milieu of polycystic ovary syndrome (PCOS). Design: Single arm open label trial. Methods …

The new millennium has brought intense focus of interest on the risk of cardiovascular
disease in women. The polycystic ovary syndrome (PCOS) is a common endocrine disorder …

Clearly presented and thoroughly up to date, this important text provides an overview of
current knowledge of the polycystic ovary syndrome (PCOS)-its etiology, pathology, and the …

There is increasing evidence that elevated plasma levels of hemostatic factors [fibrinogen,
factor VII, von Willebrand factor, fibrin d-dimer, and tissue plasminogen activator (t-PA) …

Background: Polycystic ovary syndrome (PCOS) occurs in around 10% women of
reproductive age and is characterised by obesity, hyperandrogenism, insulin resistance and …

Transvaginal ultrasound is currently the gold standard for diagnosing polycystic ovaries. The
results of studies using ultrasound suggest a prevalence in young women of at least 20 …

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder that affects
reproductive-age women. Hyperandrogenemia is present in a significant fraction (~ 80%) of …

Aims: Central obesity and insulin resistance are strongly implicated in the etiology of
polycystic ovarian syndrome (PCOS) and their reduction is therefore a central treatment …